The accreditors of this session require that you periodically check in to verify that you are still attentive.
Please click the button below to indicate that you are.
Select appropriate treatment regimens for newly diagnosed multiple myeloma based on current guidelines, patient characteristics, and potential benefits and risks.
Apply knowledge of treatment options, risks and benefits, and practice guidelines to select specific treatment regimens for patients with relapsed or refractory multiple myeloma.
Provide comprehensive patient-centric care that accounts for the preferences, treatment goals, side effects, and
supportive care needs of patients with multiple myeloma.
Speaker(s):
Rachid
Baz,
Senior Member, Multiple Myeloma Section Head, Department of Malignant Hematology,
Moffitt Cancer Center